This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In 2025, pharma marketing news is filled with innovation, disruption, and opportunities to grow your business. In 2025, digital channels dominate marketing strategies as companies shift from traditional campaigns to online platforms. Lets dive into the trends shaping the industry and how you can use them to craft winning strategies.
It means using data responsibly to tailor content, recommend resources, and support adherenceall while complying with HIPAA and other healthcare regulations. Ad copy and landing pages must include ISI (Important Safety Information), follow FDA and PhRMA guidelines, and offer fair balance when promoting branded products.
This guide explores essential strategies to ensure your team is prepared for the shifting dynamics of healthcare marketing in 2025 and beyond. Regulatory frameworks such as HIPAA, GDPR, and FDA guidelines dictate how pharmaceutical brands can advertise and engage with healthcare professionals (HCPs) and patients.
Given the public health emergency, health authorities offered greater flexibilities in the use of digital health platforms and technologies such as: Enhanced HIPAA (Health Insurance Portability and Accountability Act of 1996) flexibilities in the use of telemedicine services 3.
In December 2021, the US FDA issued a cross-center draft guidance with recommendations on the use of digital health technology tools (DHTTs) to acquire data remotely from participants in clinical investigations for medical products. Table 3: Example classification of DHTs. .
This article dives deep into how patient marketing has changed, whats driving this transformation, and what strategies are leading the way for 2025 and beyond. These tools help pharma brands deliver HIPAA-compliant, personalized content to segmented audiences based on health behavior and condition.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content